Introduction to NCE Biotech, LLC, Research Triangle Park, North Carolina USA

NCE Biotech is a multi-disciplinary advisory practice, with unique skills in biotechnology company strategic thinking, corporate development transactions, drug development alliances, product strategy/development, and business development executive management.

Our deal experience covers - mergers, strategic drug development and discovery alliances, spin-offs, and the establishment of joint venture companies. Services provided:

· Handle the business and drug due diligence aspect of drug acquisitions and divestitures

· General biotechnology business development capabilities for biotech companies

· Spreadsheet tools and expertise to conduct in-depth drug valuation assessments

· Ability to conduct pharmaceutical partnership programs for biotech companies

· U.S. representative for European and Asia companies and hospitals

· Drug acquisition scouting

· Identify solid bio-pharma therapeutic business programs

Background

Eric Nelson has 20 years of experience in the biotech and pharma industry. He has worked in business development position at Advinus Therapeutics, Tranzyme Pharma, Wyeth Pharmaceuticals, and Athena Neurosciences/Elan; and in investment banking at SG Cowen.

He has completed 6 successful biotechnology company IPO and acquisition exits, and completed 30 large compound licensing and drug discovery strategic alliances.

Consulting Services for Biotechnology Companies

· Implementing pharma company partnering programs

· Financial valuation assessments of drug programs

· Assess deal comps, construct term sheets for partnering deals, lead M&A initiatives

· Drug competitive assessments and attendance at scientific meetings

· U.S.-India asset spin-outs, strategic alliances, risk-sharing deals with CROs

· Drug acquisition scouting

Drug Valuation Assessments

· It is expected that biotech companies with drugs entering clinical trials have solid valuation assessments of their drugs. We have powerful and easy to use financial spreadsheet drug valuation tools that can be used across the company by teams, and by the CEO for modeling scenarios, carry-out drug valuation assessments by collecting all of the variables needed, and linking the valuation model to term sheets.

· These models can be used to model even the most complete drug development programs

· We have both simple and more complex, highly polished valuation models, with impressive report read-outs, that we can provide to a biotechnology company team.

US – India Business Development

· Identify India drug discovery and development partners

· Explore the option of risk-sharing drug development deals with India companies

· Provide competitive intelligence and meeting attendance for Indian drug discovery companies

Drug Due Diligence Assessments

· Organize and manage drug due diligence teams

Drug Acquisition Scouting

· Scouting for and prioritize drug acquisition candidates

Establish advisory panels, provide solid therapeutic area expertise, and therapeutic area drug development network

Contact:

Dr. Eric Nelson, Partner

Research Triangle Park, North Carolina USA

Tel: +1-919-332-9080

Email: enelson@ncebiotech.com